Impulse control disorders in Parkinson’s disease: Predominant role of psychological determinants

References

• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
   Google Scholar
• Bjelland, I., Dahl, A., Haug, T., & Neckelmann, D. (2002). The validity of the hospital anxiety and depression scale. Journal of Psychosomatic Research, 52, 69–77. doi:10.1016/S0022-3999(01)00296-3
   PubMed Web of Science ®Google Scholar
• Bohlmeijer, E., Prenger, R., Taal, E., & Cuijpers, P. (2010). The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: A meta-analysis. Journal of Psychosomatic Research, 68, 539–544. doi:10.1016/j.jpsychores.10.005
   PubMed Web of Science ®Google Scholar
• Bramley, N., & Eatough, V. (2005). The experience of living with Parkinson’s disease: An interpretative phenomenological analysis case study. Psychology and Health, 20, 223–235. doi:10.1080/08870440412331296053
   Web of Science ®Google Scholar
• Carver, C. S. (1997). You want to measure coping but your protocol’ too long: Consider the brief cope. International Journal of Behavioral Medicine, 4, 92–100. doi:10.1207/s15327558ijbm0401_6
   PubMed Web of Science ®Google Scholar
• Carver, C. S., Scheier, M. F., & Weintraub, J. K. (1989). Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology, 56, 267–283. doi:10.1037//0022-3514.56.2.267
   PubMed Web of Science ®Google Scholar
• Ceschin, L., Giannunzio, V., Favaro, A., & Santonastaso, P. (2010). Pica in an eating disordered woman with multiple sclerosis: Impulse dys-control, compulsive symptom or self-medication attempt? Eating and Weight Disorders, 15, e116–e118.
   PubMed Web of Science ®Google Scholar
• Chaudhuri, K. R., & Schapira, A. H. (2006). Non-motor symptoms of Parkinson’s disease: Dopaminergic pathophysiology and treatment. The Lancet Neurology, 8, 464–474. doi:10.1016/S1474-4422(09)70068-7
   Google Scholar
• Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006). Non-motor symptoms of Parkinson's disease: Diagnosis and management. The Lancet Neurology, 5, 235–245. doi:10.1016/S1474-4422(06)70373-8
   PubMed Web of Science ®Google Scholar
• Coccaro, E. F., & Schmidt-Kaplan, C. A. (2012). Life history of impulsive behavior: Development and validation of a new questionnaire. Journal of Psychiatric Research, 46, 346–352. doi:10.1016/j.jpsychires.2011.11.008
   PubMed Web of Science ®Google Scholar
• Crawford, J. R., & Henry, J. D. (2010). The depression anxiety stress scales (DASS): Normative data and latent structure in a large nonclinical sample. British Journal of Clinical Psychology, 42, 111–131. doi:10.1348/014466503321903544
   Web of Science ®Google Scholar
• Cukor, D. (2007). Use of CBT to treat depression among patients on hemodialysis. Psychiatric Services, 58, 711–712. doi:10.1176/appi.ps.58.5.711
   PubMed Web of Science ®Google Scholar
• Dahl, J. A., Wilson, K. G., & Nilsson, A. (2004). Acceptance and commitment therapy and the treatment of persons at risk for long-term disability resulting from stress and pain symptoms: A preliminary randomized trial. Behavior Therapy, 35, 1016. doi:10.1016/S0005-7894(04)80020-0
   Web of Science ®Google Scholar
• Delaney, M., Simpson, J., & Leroi, I. (2011). Perceptions of cause and control of impulse control behaviours in people with Parkinson’s disease. British Journal of Health Psychology, 17, 522–535. doi:10.1111/j.2044-8287.2011.02052.x
   PubMed Web of Science ®Google Scholar
• Delaney, M., Leroi, I., Simpson, J., & Overton, P. G. (2012). Impulse control disorders in Parkinson’s disease: A psychosocial perspective. Journal of Clinical Psychology in Medical Settings, 19, 338–346. doi:10.1007/s10880-012-9302-7
   PubMed Web of Science ®Google Scholar
• Dell’Osso, B., Altamura, A. C., Allen, A., Marazziti, D., & Hollander, E. (2006). Epidemiologic and clinical updates on impulse control disorders: A critical review. European Archives of Psychiatry & Clinical Neuroscience, 256, 464–475. doi:10.1007/s00406-006-0668-0
   PubMed Web of Science ®Google Scholar
• Department for Constitutional Affairs. (2007). Mental capacity act 2005: Code of practice. London: The Stationary Office.
   Google Scholar
• Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., & Bienfait, K. L. (2011). Cognitive-behavioral therapy for depression in Parkinson's disease: A randomized, controlled trial. American Journal of Psychiatry, 168, 1066–1074. doi:10.1176/appi.ajp.2011.10111669
   PubMed Web of Science ®Google Scholar
• Dobson, C. (2008). Conducting research with people not having the capacity to consent to their participation: A practical guide for researchers. Leicester: British Psychological Society.
   Google Scholar
• Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, E. (2005). Pathological gambling caused by drugs used to treat Parkinson’s disease. Archives of Neurology, 62, 1–5. doi:10.1001/archneur.62.9.noc50009
   Google Scholar
• Durbin, J., & Watson, G. S. (1971). Testing for serial correlation in least squares regression. III. Biometrika, 58, 1–19. doi:10.1093/biomet/58.1.1
   Web of Science ®Google Scholar
• Edgar, K. A., & Skinner, T. C. (2003). Illness representations and coping as predictors of emotional well-being in adolescents with type 1 diabetes. Journal of Pediatric Psychology, 28, 485–493. doi:10.1093/jpepsy/jsg039
   PubMed Web of Science ®Google Scholar
• Ferrara, J. M., & Stacy, M. (2008). Impulse-control disorders in Parkinson’s disease. CNS Spectrums, 13, 690–698. doi:10.1017/S1092852900013778
   PubMed Web of Science ®Google Scholar
• Field, A. (2009). Discovering statistics using SPSS (3rd ed.). London: Sage.
   Google Scholar
• Fitzpatrick, L., Simpson, J., & Smith, A. (2010). A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson’s disease. Psychology and Psychotherapy: Theory, Research and Practice, 83, 179–192. doi:10.1348/147608309X471514
   PubMed Web of Science ®Google Scholar
• Gallagher, D. A., Lees, A. J., & Schrag, A. (2010). What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Movement Disorders, 25, 2493–2500. doi:10.1002/mds.23394
   PubMed Web of Science ®Google Scholar
• Gelb, D., Oliver, E., & Gilman, S. (1999). Diagnostic criteria for Parkinson disease. Archives of Neurology, 56, 33–39. doi:10.1001/archneur.56.1.33
   PubMed Web of Science ®Google Scholar
• Giladi, N., Weitzman, N., Schreiber, S., Shabtai, H., & Peretz, C. (2007). New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson’s disease: The role of dopamine agonist treatment and age at motor symptoms onset. Journal of Psychopharmacology, 21, 501–506. doi:10.1177/0269881106073109
   PubMed Web of Science ®Google Scholar
• Goerlich-Dobre, K. S., Probst, C., Winter, L., Witt, K., Deuschl, G., Möller, B., & van Eimeren, T. (2014). Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson’s disease. Movement Disorders, 29, 214–220. doi:10.1002/mds.25679
   PubMed Web of Science ®Google Scholar
• Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., … Seidl, L. 2004). Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease. Movement Disorders, 19, 1020–1028. doi:10.1002/mds.20213
   PubMed Web of Science ®Google Scholar
• Green, S. B. (1991). How many subjects does it take to do a regression analysis. Multivariate Behavioral Research, 26, 499–510. doi:10.1207/s15327906mbr2603_7
   PubMed Web of Science ®Google Scholar
• Gregg, J. A., Callaghan, G. M., Hayes, S. C., & Glenn-Lawson, J. L. (2007). Improving diabetes self-management through acceptance, mindfulness, and values: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 75, 336–343. doi:10.1037/0022-006X.75.2.336
   PubMed Web of Science ®Google Scholar
• Harris, R. J. (1985). A primer of multivariate statistics (2nd ed.). New York, NY: Academic Press.
   Google Scholar
• Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression, and mortality. Neurology, 17, 427–427. doi:10.1212/WNL.17.5.427
   PubMed Web of Science ®Google Scholar
• Hurt, C. S., Alkufri, F., Brown, R. G., Burn, D. J., Hindle, J. V., Landau, S., … Samuel, M. PROMS-PD study group. (2014). Motor phenotypes, medication and mood: Further associations with impulsive behaviours in Parkinson’s disease. Journal of Parkinson’s Disease, 4, 245–254. doi:10.3233/JPD-130314
   PubMedGoogle Scholar
• Isaias, I. U., Siri, C., Cilia, R., De Gaspari, D., Pezzoli, G., & Antonini, A. (2008). The relationship between impulsivity and impulse control disorders in Parkinson’s disease. Movement Disorders, 23, 411–415. doi:10.1002/mds.21872
   PubMed Web of Science ®Google Scholar
• Jiménez-Murcia, S., Bove, F. I., Israel, M., Steiger, H., Fernández-Aranda, F., Álvarez-Moya, E., … Granero, R. (2012). Cognitive-behavioral therapy for pathological gambling in Parkinson’s disease: A pilot controlled study. European Addiction Research, 18, 265–274. doi:10.1159/000337442
   PubMed Web of Science ®Google Scholar
• Kurlan, R. (2004). Disabling repetitive behaviors in Parkinson's disease. Movement Disorders, 19, 433–437. doi:10.1002/mds.10625.
   PubMed Web of Science ®Google Scholar
• Lee, J. Y., Kim, J. M., Kim, J. W., Cho, J., Lee, W. Y., Kim, H. J., & Jeon, B. S. (2010). Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism and Related Disorders, 16, 202–207. doi:10.1016/j.parkreldis.2009.12.002
   PubMed Web of Science ®Google Scholar
• Leventhal, H., Nerenz, D., & Steele, D. J. (1984). Illness representations and coping with health threats. In A. Baum (Ed.), Handbook of psychology and health: Social psychological aspects of health (pp. 219–252). Hillsdale: Lawrence Erlbaum.
   Google Scholar
• Llewellyn, C. D., McGurk, M., & Weinman, J. (2007). Illness and treatment beliefs in head and neck cancer: Is Leventhal’s common sense model a useful framework for determining changes in outcomes over time? Journal of Psychosomatic Research, 63, 17–26. doi:10.1016/j.jpsychores.2007.01.013
   PubMed Web of Science ®Google Scholar
• Lim, S. Y., Evans, A. H., & Miyasaki, J. M. (2008). Impulse control and related disorders in Parkinson's disease. Annals of the New York Academy of Sciences, 1142, 85–107. doi:10.1196/annals.1444.006
   PubMed Web of Science ®Google Scholar
• Lovibond, S. H., & Lovibond, P. F. (1995). Manual for the depression anxiety stress scales (2nd ed.). Sydney: Psychology Foundation.
   Google Scholar
• Lundgren, T., Dahl, J. A., Melin, L., & Kies, B. (2006). Evaluation of acceptance and commitment therapy for drug refractory epilepsy: A randomized controlled trial in South Africa – a pilot study. Epilepsia, 47, 2173–2179. doi:10.1111/j.1528-1167.2006.00892.x/asset/j.1528-1167.2006.00892.x.pdf
   PubMed Web of Science ®Google Scholar
• Macphee, G., & Carson, A. (2013). Impulse control disorders in Parkinson disease: Is cognitive-behavioral therapy worth a wager? Neurology, 80, 782–783. doi:10.1212/WNL.0b013e31828407ef
   PubMed Web of Science ®Google Scholar
• Mamikonyan, E., Siderowf, A. D., Duda, J. E., Potenza, M. N., Horn, S., Stern, M. B., & Weintraub, D. (2008). Long-term follow up of impulse control disorders in Parkinson’s disease. Movement Disorders, 23, 75–80. doi:10.1002/mds.21770
   PubMed Web of Science ®Google Scholar
• Marinus, J., Leentjens, A. F. G., Visser, M., Stiggelbout, A. M., & van Hilten, J. J. (2002). Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clinical Neuropharmacology, 25, 318–324. doi:10.1097/00002826-200211000-00008
   PubMed Web of Science ®Google Scholar
• Mendez, M. F., Bronstein, Y. L., & Christine, D. L. (2000). Excessive sweepstakes participation by persons with dementia. Journal of the American Geriatrics Society, 48, 855–856. doi:10.1111/j.1532-5415.2000.tb04770.x
   PubMed Web of Science ®Google Scholar
• Minzer, K., Lee, O., Hong, J. J., & Singer, H. S. (2004). Increased prefrontal D2 protein in Tourette syndrome: A postmortem analysis of frontal cortex and striatum. Journal of the Neurological Sciences, 219, 55–61. doi:10.1016/j.jns.2003.12.006
   PubMed Web of Science ®Google Scholar
• Moore, R. Y. (2003). Organization of midbrain dopamine systems and the pathophysiology of Parkinson’s disease. Parkinsonism and Related Disorders, 9( Suppl 2), 65–71. doi:10.1016/S1353-8020(03)00063-4
   Web of Science ®Google Scholar
• Moss-Morris, R., Weinman, J., Petrie, K., Horne, R., Cameron, L., & Buick, D. (2002). The revised illness perception questionnaire (IPQ-R). Psychology and Health, 17, 1–16. doi:10.1080/08870440290001494
   Web of Science ®Google Scholar
• Obeso, J. A., Rodriguez-Oroz, M. C., Rodriguez, M., Lanciego, J. L., Artieda, J., Gonzalo, N., & Olanow, C. W. (2000). Pathophysiology of the basal ganglia in Parkinson’s disease. Trends in Neurosciences, 23, S8–S19. doi:10.1016/S1471-1931(00)00028-8
   PubMed Web of Science ®Google Scholar
• Okai, D., Askey-Jones, S., Samuel, M., O’Sullivan, S. S., Chaudhuri, K. R., Martin, A., … Mack, J. (2013). Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology, 80, 792–799. doi:10.1212/WNL.0b013e3182840678
   PubMed Web of Science ®Google Scholar
• Osborne, J. W. (2010). Improving your data transformations: Applying the Box-Cox transformation. Practical Assessment, 15, 1–9. Retrieved from http://pareonline.net/getvn.asp?v=15&n=12
   Google Scholar
• Papay, K., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Lyons, K. E., Pahwa, R., … ,Weintraub, D. (2011). Patient versus informant reporting of ICD symptoms in Parkinson’s disease using the QUIP: Validity and variability. Parkinsonism and Related Disorders, 17, 153–155. doi:10.1016/j.parkreldis.2010.11.015
   PubMed Web of Science ®Google Scholar
• Perez-Lloret, S., Rey, M. V., Fabre, N., Ory, F., Spampinato, U., Brefel-Courbon, C., … Rascol, O. (2012). Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease. Clinical Neuropharmacology, 35, 261–265. doi:10.1097/WNF.0b013e31826e6e6d
   PubMed Web of Science ®Google Scholar
• Phu, A. L., Xu, Z., Brakoulias, V., Mahant, N., Fung, V. S. C., De Moore, G., … Krause, M. (2014). Effect of impulse control disorders on disability and quality of life in Parkinson’s disease patients. Journal of Clinical Neuroscience, 21, 1–4. doi:10.1016/j.jocn.2013.02.032
   PubMed Web of Science ®Google Scholar
• Pietrzak, R. H., Morasco, B. J., Blanco, C., Grant, B. F., & Petry, N. M. (2007). Gambling level and psychiatric and medical disorders in older adults: Results from the National epidemiologic survey on alcohol and related conditions. The American Journal of Geriatric Psychiatry, 15, 301–313. doi:10.1097/01.JGP.0000239353.40880.cc
   PubMed Web of Science ®Google Scholar
• Poletti, M., Logi, C., Lucetti, C., Del Dotto, P., Baldacci, F., Vergallo, A., … Ulivi, M. (2013). A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease. Journal of Clinical Psychopharmacology, 33, 691–694. doi:10.1097/JCP.0b013e3182979830
   PubMed Web of Science ®Google Scholar
• Rodriguez-Violante, M., Gonzalez-Latapi, P., Cervantes-Arriaga, A., Camacho-Ordonez, A., & Weintraub, D. (2014). Impulse control and related disorders in Mexican Parkinson’s disease patients. Parkinsonism & Related Disorders, 20, 907–910. doi:10.1016/j.parkreldis.05.014
   PubMed Web of Science ®Google Scholar
• Schmidt, C. A., Fallon, A. E., & Coccaro, E. F. (2004). Assessment of behavioral and cognitive impulsivity: Development and validation of the lifetime history of impulsive behaviors interview. Psychiatry Research, 126, 107–121. doi:10.1016/j.psychres.2003.12.021
   PubMed Web of Science ®Google Scholar
• Schrag, A., Dodel, R., Spottke, A., Bornschein, B., Siebert, U., & Quinn, N. P. (2007). Rate of clinical progression in Parkinson's disease. A prospective study. Movement Disorders, 22, 938–945. doi:10.1002/mds.21429
   PubMed Web of Science ®Google Scholar
• Schrag, A., Hovris, A., Morley, D., Quinn, N., & Jahanshahi, M. (2003). Young-versus older-onset Parkinson’s disease: Impact of disease and psychosocial consequences. Movement Disorders, 18, 1250–1256. doi:10.1002/mds.10527
   PubMed Web of Science ®Google Scholar
• Schwab, R. S., & England, A. C. (1969). Projection technique for evaluating surgery in Parkinson’s disease. In F. J. Gillingham & M. C. Donaldson (Eds.), Third symposium on Parkinson’s disease (pp. 152–157). Edinburgh: E. S. Livingstone.
   Google Scholar
• Simpson, J., & Thomas, C. (2015). Clinical psychology and disability studies: Bridging the disciplinary divide on mental health and disability. Disability and Rehabilitation, 37, 1299–1304. doi:10.3109/09638288.2014.961656
   PubMed Web of Science ®Google Scholar
• Simpson, J., Lekwuwa, G., & Crawford, T. (2013). Illness beliefs and psychological outcome in people with Parkinson’s disease. Chronic Illness, 9, 165–176. doi:10.1177/1742395313478219117
   PubMedGoogle Scholar
• Simpson, J., McMillan, H., & Reeve, D. (2013). Reformulating psychological difficulties in people with Parkinson's disease: The potential of a social relational approach to disablism. Parkinson’s Disease, 2013, 8 pp., Article ID 608562. doi:10.1155/2013/608562
   Google Scholar
• Simpson, J., Haines, K., Lekwuwa, G., Wardle, J., & Crawford, T. (2006). Social support and psychological outcome in people with Parkinson’s disease: Evidence for a specific pattern of associations. British Journal of Clinical Psychology, 45, 585–590. doi:10.1348/014466506X96490
   PubMed Web of Science ®Google Scholar
• Simpson, J., Lekwuwa, G., & Crawford, T. (2014). Predictors of quality of life in people with Parkinson’s disease: Evidence for both domain specific and general relationships. Disability and Rehabilitation, 36, 1964–1970. doi:10.3109/09638288.2014.883442
   PubMed Web of Science ®Google Scholar
• Snaith, R. P. (2003). The hospital anxiety and depression scale. Health and Quality of Life Outcomes, 1, 29–32. doi:10.1186/1477-7525-1-29
   PubMedGoogle Scholar
• Stern, M. B. (1988). The clinical characteristics of Parkinson’s disease and Parkinsonian syndromes: Diagnosis and assessment. In M. B. Stern (Ed.), The comprehensive management of Parkinson’s disease (pp. 3–50). New York, NY: PMA Publishing.
   Google Scholar
• Steyerberg, E. W., Harrell, F. E., Jr, Borsboom, G. J., Eijkemans, M. J., Vergouwe, Y., & Habbema, J. D. (2001). Internal validation of predictive models. Journal of Clinical Epidemiology, 54, 774–781. doi:10.1016/S0895-4356(01)00341-9
   PubMed Web of Science ®Google Scholar
• Tabachnick, B. G., & Fidell, L. S. (2007). Using multivariate statistics (5th ed.). Boston, MA: Pearson Education , Allyn and Bacon.
   Google Scholar
• Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010). Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Movement Disorders, 25, 2649–2653. doi:10.1002/mds.23429
   PubMed Web of Science ®Google Scholar
• Vilas, D., Pont-Sunyer, C., & Tolosa, E. (2011). Impulse control disorders in Parkinson’s disease. Parkinsonism & Related Disorders, 18, S80–S84. doi:10.1016/S1353-8020(11)70026-8
   Google Scholar
• Voon, V., & Fox, S. H. (2007). Medication-related impulse control and repetitive behaviors in Parkinson disease. Archives of Neurology, 64, 1089–1096. doi:10.1001/archneur.64.8.1089
   PubMedGoogle Scholar
• Voon, V., Potenza, M. N., & Thomsen, T. (2007). Medication-related impulse control and repetitive behaviors in Parkinson’s disease. Current Opinion in Neurology, 20, 484–492. doi:10.1097/WCO.0b013e32826fbc8f
   PubMed Web of Science ®Google Scholar
• Voon, V., Sohr, M., Lang, A. E., Potenza, M. N., Siderowf, A. D., Whetteckey, J., … Stacy, M. (2011). Impulse control disorders in Parkinson disease: A multicenter case-control study. Annals of Neurology, 69, 986–996. doi:10.1002/ana.22356
   PubMed Web of Science ®Google Scholar
• Weintraub, D. (2008). Dopamine and impulse control disorders in Parkinson’s disease. Annals of Neurology, 64, S93–S100. doi:10.1002/ana.21454
   Google Scholar
• Weintraub, D., Mamikonyan, E., Papay, K., Shea, J. A., Xie, S. X., & Siderowf, A. (2012). Questionnaire for impulsive-compulsive disorders in Parkinson’s disease-rating scale. Movement Disorders, 27, 242–247. doi:10.1002/mds.24023
   PubMed Web of Science ®Google Scholar
• Weintraub, D., Potenza, M. N., Siderowf, A. D., & Voon, V. (2010). Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Archives of Neurology, 67, 589–595. doi:10.1001/archneurol.2010.65
   PubMed Web of Science ®Google Scholar
• Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E., … Moberg, P. J. (2006). Association of dopamine agonist use with impulse control disorders in Parkinson disease. Archives of Neurology, 63, 969–973. doi:10.1001/archneur.63.7.969
   PubMed Web of Science ®Google Scholar
• Wetherell, J. L., Afari, N., Rutledge, T., Sorrell, J. T., Stoddard, J. A., Petkus, A. J., … Solomon, B.C. (2011). A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain, 152, 2098–2107. doi:10.1016/j.pain.2011.05.016
   PubMed Web of Science ®Google Scholar
• Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar